TG
CARM

TCW Group’s Carisma Therapeutics CARM Stock Holding History

TCW Group’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,988
Closed -$355K – 671
2015
Q1 		$355K Sell
1,988
-165
-8% -$36K ﹤0.01% 740
2014
Q4 		$512K Buy
2,153
+245
+13% +$54.9K ﹤0.01% 707
2014
Q3 		$425K Sell
1,908
-568
-23% -$135K ﹤0.01% 715
2014
Q2 		$654K Sell
2,476
-2,802
-53% -$693K ﹤0.01% 709
2014
Q1 		$1.71M Buy
+5,278
New +$1.58M 0.01% 682

Other funds holding CARM

TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

TCW Group's CARM Position: Q2 2015 in Review

TCW Group sold out of Carisma Therapeutics (CARM) in Q2 2015, closing a stake of 1,988 shares — an estimated $355K sold.

TCW Group first reported a position in CARM in Q1 2014 and held it in 5 quarters. The position peaked at $1.71M in Q1 2014. 41 funds tracked by Wall St. Rank hold CARM as of Q2 2015.

  • TCW Group reported no remaining Carisma Therapeutics position as of Q2 2015 after selling out during the quarter.
  • TCW Group sold 1,988 Carisma Therapeutics shares in Q2 2015, an estimated $355K.
  • TCW Group first reported a position in Carisma Therapeutics in Q1 2014 and held it in 5 quarters.
  • TCW Group's Carisma Therapeutics position peaked at $1.71M in Q1 2014.
  • 41 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q2 2015.

Based on TCW Group's 13F filing for Q2 2015, filed 12 Aug 2015.